Key points are not available for this paper at this time.
CAB-LA was superior to daily oral TDF-FTC in preventing HIV infection among MSM and transgender women. Strategies are needed to prevent INSTI resistance in cases of CAB-LA PrEP failure. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 083 ClinicalTrials.gov number, NCT02720094.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Raphael J. Landovitz
Deborah Donnell
Meredith E. Clement
Civil War Book Review
New England Journal of Medicine
Johns Hopkins University
National Institutes of Health
Cornell University
Building similarity graph...
Analyzing shared references across papers
Loading...
Landovitz et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d75bc7086f9d6299f30a83 — DOI: https://doi.org/10.1056/nejmoa2101016
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: